The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy.
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy.
复制标题
DOI：
10.3390/pharmaceutics14061228
复制
发表时间：
2022-06-10
期刊：
影响因子：
5.4
通讯作者：
Zhang, Zhiyue
中科院分区：
文献类型：
--
作者：
Huang, Lingling;Ge, Xiaoyan;Liu, Yang;Li, Hui;Zhang, Zhiyue
Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a critical role in innate and adaptive immunity. Toll-like receptor agonists (TLRa) as vaccine adjuvant candidates have become one of the recent research hotspots in the cancer immunomodulatory field. Nevertheless, numerous current systemic deliveries of TLRa are inappropriate for clinical adoption due to their low efficiency and systemic adverse reactions. TLRa-loaded nanoparticles are capable of ameliorating the risk of immune-related toxicity and of strengthening tumor suppression and eradication. Herein, we first briefly depict the patterns of TLRa, followed by the mechanism of agonists at those targets. Second, we summarize the emerging applications of TLRa-loaded nanomedicines as state-of-the-art strategies to advance cancer immunotherapy. Additionally, we outline perspectives related to the development of nanomedicine-based TLRa combined with other therapeutic modalities for malignancies immunotherapy.
登录
查看更多内容
Toll样受体在炎症和肿瘤免疫中的作用
影响因子：
5.6
作者：
Cen X;Liu S;Cheng K
通讯作者：
Cheng K
影响因子：
10.9
作者：
Angela Aznar, M.;Planelles, Lourdes;Melero, Ignacio
通讯作者：
Melero, Ignacio
影响因子：
5.6
作者：
Caisova, Veronika;Uher, Ondrej;Zenka, Jan
通讯作者：
Zenka, Jan
影响因子：
10.8
作者：
Bayyurt, Banu;Tincer, Gizem;Gursel, Ihsan
通讯作者：
Gursel, Ihsan
影响因子：
50.5
作者：
Belani, C. P.;Chakraborty, B. C.;Khamar, B. M.
通讯作者：
Khamar, B. M.